If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



ACS Spring 2021 call for papers

Divisions issue calls for abstracts for the April 5–16 meeting

December 17, 2020 | A version of this story appeared in Volume 98, Issue 48


This is an image of the ACS meeting logo.

American Chemical Society divisions have issued calls for abstracts for the ACS Spring 2021 meeting, to be held April 5–16.

ACS’s online Meeting Abstracts Programming System opened Dec. 16 for ACS Spring 2021 abstracts. Please visit to submit abstracts; the deadline is Jan. 19.

The society standing rule governing presentation of papers appears below.

Standing rule VI, section 8, “Presentation of Papers”:

a. The term “paper” shall include any scientific presentation that can be reduced to writing.

b. No paper shall be presented at a national, regional, divisional, or other major meeting unless its title and author(s) appear on the program for the meeting. However, the President, with the concurrence of either the Chair of the Board of Directors or the Vice-Chair of the Council Policy Committee, may authorize an extraordinary symposium at a national meeting provided that

(1) the symposium has as its primary focus significant scientific developments too recent for programming deadlines, and

(2) the request for authorization for such a symposium has been made jointly by a member of the SOCIETY and one of the following: the Chair of a relevant Division of the SOCIETY, the Chair of the Committee on Divisional Activities, or the Chair of the Committee on Science.

c. No paper by a chemical scientist residing in the United States who is not a member of the SOCIETY shall appear on the program of a national, regional, divisional, or other major meeting of the SOCIETY unless it be a joint paper with one or more SOCIETY members, or unless for a national, regional, or national-divisional meeting the author has been invited to present the paper at a symposium organized by a Division of the SOCIETY or by Sections of the SOCIETY, and the Chair of such Division or of the host Section has certified to the Chief Executive Officer prior to publication of the program that presentation by the author of such paper is important to the success of the symposium.

d. Rules corresponding to paragraphs a, b, and c of this section for a cooperative meeting shall be subject to agreement in advance between the organizations concerned but should conform, insofar as possible, to this Standing Rule and be subject to approval by the Chief Executive Officer.

e. The SOCIETY assumes no responsibility for statements or opinions expressed by individuals in papers or discussions thereof.

f. The President shall have authority to exclude any paper from a program at any time prior to its scheduled presentation at a meeting of the SOCIETY.

Regulation V, number 3, supplements standing rule VI, section 8, as follows:

a. Authorship of papers shall be accredited only to individuals and not to companies or laboratories.

b. Therapeutic Papers. It is the policy of the SOCIETY to encourage the presentation of chemical papers with pharmacological and physiological aspects, but to discourage presentation, by other than qualified clinical investigators, of papers in which clinical interpretations are the principal contribution. All Divisions and other programming units shall adhere to this policy when determining the acceptability of papers for their meeting programs. The Divisions and other programming units also are urged to exclude from their programs, and especially from any abstracts issued, statements recommending procedures for the treatment of human disease or announcement of any “cures” not confirmed by competent medical authority. Any author contributing a paper that includes discussion of the treatment of human disease must submit for review, by representatives of the appropriate Division or other programming unit, a complete manuscript in addition to an abstract.

Notes: Submission of papers for presentation at an ACS meeting does not constitute submission for publication in an ACS journal. Regulations for accepting papers to be presented as part of divisional meetings vary for each division. However, publication of papers in ACS journals is based on the earliest date of receipt of the complete paper by the appropriate editor.

The council has empowered officers of divisions to request any paper in advance so that they may review it and decide whether the author should read the entire paper or abstract it to allow time for discussion.

Submitters should pay special attention to the misuse of trade names, secret formulas, and secret processes in papers at meetings of the society.

ACS requests that authors avoid the use of trade names in papers presented at ACS meetings. Chairs are responsible for enforcing this policy.

For a complete list of divisions’ symposia, please visit



This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.